Growth Metrics

Rigel Pharmaceuticals (RIGL) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -45.45%
Jun 30, 2025 -50.43%
Mar 31, 2025 -45.71%
Dec 31, 2024 -44.24%
Sep 30, 2024 -47.89%
Jun 30, 2024 -46.51%
Mar 31, 2024 -52.38%
Dec 31, 2023 -80.75%
Sep 30, 2023 -88.78%
Jun 30, 2023 -88.26%
Mar 31, 2023 -86.26%
Dec 31, 2022 -60.76%
Sep 30, 2022 -36.20%
Jun 30, 2022 -31.26%
Mar 31, 2022 -14.33%
Dec 31, 2021 -18.39%
Sep 30, 2021 5.48%
Jun 30, 2021 11.93%
Mar 31, 2021 -3.74%
Dec 31, 2020 23.95%
Sep 30, 2020 46.51%
Jun 30, 2020 55.42%
Mar 31, 2020 62.19%
Dec 31, 2019 55.66%
Sep 30, 2019 16.00%
Jun 30, 2019 3.23%
Mar 31, 2019 11.19%
Dec 31, 2018 58.51%
Sep 30, 2018 61.15%
Jun 30, 2018 51.12%
Mar 31, 2018 34.24%
Dec 31, 2017 -24.31%
Sep 30, 2017 -28.98%
Jun 30, 2017 -37.89%
Mar 31, 2017 -33.42%
Dec 31, 2016 -28.33%
Sep 30, 2016 -28.78%
Jun 30, 2016 -12.65%
Mar 31, 2016 -23.55%
Dec 31, 2015 -35.71%
Sep 30, 2015 -36.51%
Jun 30, 2015 -47.23%
Mar 31, 2015 -47.06%
Dec 31, 2014 -43.68%
Sep 30, 2014 -42.04%
Jun 30, 2014 -37.11%
Mar 31, 2014 -31.80%
Dec 31, 2013 -23.53%
Sep 30, 2013 -15.75%
Jun 30, 2013 -10.77%
Mar 31, 2013 -1.20%
Dec 31, 2012 19.34%
Sep 30, 2012 12.22%
Jun 30, 2012 18.27%
Dec 31, 2011 7.68%